Symbols / HUM $166.45 -2.33%
HUM Chart
About
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Healthcare Plans | Market Cap | 20.07B |
| Enterprise Value | 13.52B | Income | 1.19B | Sales | 129.66B |
| Book/sh | 146.42 | Cash/sh | 165.04 | Dividend Yield | 213.00% |
| Payout | 35.98% | Employees | 67060 | IPO | — |
| P/E | 16.92 | Forward P/E | 10.89 | PEG | — |
| P/S | 0.15 | P/B | 1.14 | P/C | — |
| EV/EBITDA | 3.79 | EV/Sales | 0.10 | Quick Ratio | 1.53 |
| Current Ratio | 2.00 | Debt/Eq | 74.81 | LT Debt/Eq | — |
| EPS (ttm) | 9.84 | EPS next Y | 15.29 | EPS Growth | — |
| Revenue Growth | 11.30% | Earnings | 2026-04-29 | ROA | 4.30% |
| ROE | 7.04% | ROIC | — | Gross Margin | 14.54% |
| Oper. Margin | -1.79% | Profit Margin | 0.92% | Shs Outstand | 120.05M |
| Shs Float | 120.29M | Short Float | 4.69% | Short Ratio | 1.61 |
| Short Interest | — | 52W High | 315.35 | 52W Low | 163.60 |
| Beta | 0.41 | Avg Volume | 1.91M | Volume | 1.50M |
| Target Price | $212.17 | Recom | Hold | Prev Close | $170.42 |
| Price | $166.45 | Change | -2.33% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-02-25 | main | Barclays | Equal-Weight → Equal-Weight | $176 |
| 2026-02-18 | main | Wells Fargo | Equal-Weight → Equal-Weight | $206 |
| 2026-02-17 | main | Goldman Sachs | Sell → Sell | $158 |
| 2026-02-17 | main | Truist Securities | Hold → Hold | $200 |
| 2026-02-13 | main | TD Cowen | Hold → Hold | $173 |
| 2026-02-12 | main | Jefferies | Buy → Buy | $235 |
| 2026-02-12 | main | UBS | Neutral → Neutral | $195 |
| 2026-02-12 | down | RBC Capital | Outperform → Sector Perform | $189 |
| 2026-02-12 | main | Guggenheim | Buy → Buy | $252 |
| 2026-02-12 | main | Cantor Fitzgerald | Neutral → Neutral | $201 |
| 2026-02-02 | down | Morgan Stanley | Equal-Weight → Underweight | $174 |
| 2026-01-07 | down | Wells Fargo | Overweight → Equal-Weight | $290 |
| 2026-01-05 | main | Barclays | Equal-Weight → Equal-Weight | $245 |
| 2025-12-18 | main | Morgan Stanley | Equal-Weight → Equal-Weight | $262 |
| 2025-12-05 | up | Jefferies | Hold → Buy | $313 |
| 2025-11-25 | main | Barclays | Equal-Weight → Equal-Weight | $234 |
| 2025-11-10 | main | Truist Securities | Hold → Hold | $285 |
| 2025-11-07 | main | Deutsche Bank | Hold → Hold | $231 |
| 2025-10-10 | main | B of A Securities | Neutral → Neutral | $300 |
| 2025-10-09 | main | Mizuho | Outperform → Outperform | $345 |
News
RSS: Latest HUM news- How Low Can HUM Really Go In A Market Crash? - Trefis Fri, 20 Mar 2026 05
- Here’s Why Humana Stock Has a 270% Long-Term Upside Case - TIKR.com ue, 03 Mar 2026 08
- Is It Time To Reconsider Humana (HUM) After A 37% One Year Share Price Fall - Yahoo Finance UK hu, 19 Mar 2026 22
- Why is Humana (HUM) down 8.5% since last earnings report? - MSN Fri, 20 Mar 2026 00
- The Bear Case: How HUM Behaves During Market Shocks - Trefis hu, 19 Mar 2026 09
- CSM Advisors LLC Lowers Stock Holdings in Humana Inc. $HUM - MarketBeat ue, 17 Mar 2026 08
- Humana CEO and CFO to address investors at Leerink global healthcare conference - Stock Titan hu, 26 Feb 2026 08
- Humana’s Long Climb: Navigating The 4-STAR Recovery And The J-Curve (NYSE:HUM) - Seeking Alpha ue, 03 Mar 2026 08
- Is It Time To Reconsider Humana (HUM) After Its Steep Share Price Slide? - simplywall.st Sat, 14 Mar 2026 20
- Davis Selected Advisers Sells 1,267,195 Shares of Humana Inc. $HUM - MarketBeat hu, 19 Mar 2026 08
- Humana offers 24/7 heart hotline, remote checks for Medicare Advantage - Stock Titan ue, 03 Mar 2026 08
- Humana (HUM) Valuation Check After Prolonged Share Price Weakness And Regulatory Scrutiny - simplywall.st Sat, 28 Feb 2026 03
- Stress Testing HUM: Historical Drawdowns and Macro Risks - Trefis ue, 17 Mar 2026 10
- Long Focus Capital Management LLC Makes New $34.21 Million Investment in Humana Inc. $HUM - MarketBeat ue, 17 Mar 2026 12
- Is It Time To Reassess Humana (HUM) After Its Steep Share Price Slide - Yahoo Finance ue, 03 Mar 2026 08
Insider Transactions
| Date | Shares | Url | Text | Insider | Position | Transaction | Start Date | Ownership | Value |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 1035 | — | — | VENTURA JOSEPH CHRISTOPHER | Officer | — | 2026-02-24 00:00:00 | D | nan |
| 1 | 165 | — | — | FELTER JOHN- PAUL W. | Officer | — | 2026-02-24 00:00:00 | D | nan |
| 2 | 1035 | — | — | RENAUDIN GEORGE II | Officer | — | 2026-02-24 00:00:00 | D | nan |
| 3 | 810 | — | Purchase at price 185.20 per share. | SHETTY SANJAY K | Officer | — | 2026-02-23 00:00:00 | D | 150016.0 |
| 4 | 5669 | — | Stock Award(Grant) at price 0.00 per share. | FELTER JOHN- PAUL W. | Officer | — | 2026-02-23 00:00:00 | D | — |
| 5 | 3858 | — | — | DINTENFASS DAVID | Officer | — | 2026-02-20 00:00:00 | D | nan |
| 6 | 1682 | — | — | MEHTA JAPAN | Chief Technology Officer | — | 2026-02-13 00:00:00 | D | nan |
| 7 | 7763 | — | — | MELLET CELESTE | Chief Financial Officer | — | 2026-02-13 00:00:00 | D | nan |
| 8 | 17031 | — | Stock Award(Grant) at price 0.00 per share. | MARTIN AARON | Officer | — | 2026-02-12 00:00:00 | D | — |
| 9 | 2183 | — | — | RECHTIN JAMES A. | Chief Executive Officer | — | 2026-01-08 00:00:00 | I | nan |
Financials
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -11.66M | 0.00 | 0.00 | 50.61M |
| TaxRateForCalcs | 0.17 | 0.26 | 0.25 | 0.21 |
| TotalUnusualItems | -67.00M | 0.00 | 0.00 | 237.00M |
| TotalUnusualItemsExcludingGoodwill | -67.00M | 0.00 | 0.00 | 237.00M |
| NetIncomeFromContinuingOperationNetMinorityInterest | 1.19B | 1.21B | 2.49B | 2.81B |
| ReconciledDepreciation | 824.00M | 968.00M | 917.00M | 845.00M |
| EBIT | 2.19B | 2.38B | 3.88B | 3.97B |
| NetInterestIncome | -631.00M | -660.00M | -493.00M | -401.00M |
| InterestExpense | 631.00M | 660.00M | 493.00M | 401.00M |
| NormalizedIncome | 1.24B | 1.21B | 2.49B | 2.62B |
| NetIncomeFromContinuingAndDiscontinuedOperation | 1.19B | 1.21B | 2.49B | 2.81B |
| TotalExpenses | 128.11B | 116.04B | 102.99B | 89.30B |
| DilutedAverageShares | 120.83M | 120.87M | 124.44M | 127.09M |
| BasicAverageShares | 120.45M | 120.57M | 123.87M | 126.42M |
| DilutedEPS | 9.84 | 9.98 | 20.00 | 22.08 |
| BasicEPS | 9.87 | 10.01 | 20.09 | 22.20 |
| DilutedNIAvailtoComStockholders | 1.19B | 1.21B | 2.49B | 2.81B |
| NetIncomeCommonStockholders | 1.19B | 1.21B | 2.49B | 2.81B |
| NetIncome | 1.19B | 1.21B | 2.49B | 2.81B |
| MinorityInterests | -15.00M | -7.00M | 5.00M | 4.00M |
| NetIncomeIncludingNoncontrollingInterests | 1.20B | 1.21B | 2.48B | 2.80B |
| NetIncomeContinuousOperations | 1.20B | 1.21B | 2.48B | 2.80B |
| EarningsFromEquityInterestNetOfTax | -102.00M | -94.00M | -63.00M | -4.00M |
| TaxProvision | 250.00M | 413.00M | 836.00M | 762.00M |
| PretaxIncome | 1.55B | 1.72B | 3.38B | 3.57B |
| SpecialIncomeCharges | -67.00M | 0.00 | 0.00 | 237.00M |
| OtherSpecialCharges | 67.00M | -237.00M | ||
| NetNonOperatingInterestIncomeExpense | -631.00M | -660.00M | -493.00M | -401.00M |
| InterestExpenseNonOperating | 631.00M | 660.00M | 493.00M | 401.00M |
| OtherOperatingExpenses | 15.90B | 13.88B | 13.32B | 12.74B |
| DepreciationAndAmortizationInIncomeStatement | 698.00M | 839.00M | 779.00M | 709.00M |
| TotalRevenue | 129.66B | 117.76B | 106.37B | 92.87B |
| OperatingRevenue | 129.66B | 117.76B | 106.37B | 92.87B |
| LossAdjustmentExpense | 110.81B | 100.66B | 88.39B | 75.69B |
| NetPolicyholderBenefitsAndClaims | 110.81B | 100.66B | 88.39B | 75.69B |
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| TreasurySharesNumber | 78.13M | 78.08M | 76.47M | 73.69M |
| OrdinarySharesNumber | 120.59M | 120.64M | 122.22M | 124.97M |
| ShareIssued | 198.72M | 198.72M | 198.69M | 198.67M |
| NetDebt | 8.17B | 9.50B | 6.96B | 6.07B |
| TotalDebt | 12.37B | 11.72B | 11.66B | 11.13B |
| TangibleBookValue | 6.84B | 5.30B | 5.02B | 4.40B |
| InvestedCapital | 30.03B | 28.10B | 27.92B | 26.44B |
| NetTangibleAssets | 6.84B | 5.30B | 5.02B | 4.40B |
| CommonStockEquity | 17.66B | 16.38B | 16.26B | 15.31B |
| TotalCapitalization | 30.03B | 27.52B | 26.48B | 23.25B |
| TotalEquityGrossMinorityInterest | 17.74B | 16.45B | 16.32B | 15.37B |
| MinorityInterest | 80.00M | 70.00M | 56.00M | 59.00M |
| StockholdersEquity | 17.66B | 16.38B | 16.26B | 15.31B |
| GainsLossesNotAffectingRetainedEarnings | -633.00M | -1.07B | -999.00M | -1.30B |
| OtherEquityAdjustments | -633.00M | -1.07B | -999.00M | -1.30B |
| TreasuryStock | 14.42B | 14.37B | 13.66B | 12.16B |
| RetainedEarnings | 29.07B | 28.32B | 27.54B | 25.49B |
| AdditionalPaidInCapital | 3.60B | 3.46B | 3.35B | 3.25B |
| CapitalStock | 33.00M | 33.00M | 33.00M | 33.00M |
| CommonStock | 33.00M | 33.00M | 33.00M | 33.00M |
| PreferredStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 31.17B | 30.03B | 30.75B | 27.68B |
| NonCurrentDeferredLiabilities | 356.00M | 260.00M | 266.00M | 286.00M |
| NonCurrentDeferredRevenue | 356.00M | 260.00M | 266.00M | 286.00M |
| LongTermDebtAndCapitalLeaseObligation | 12.37B | 11.14B | 10.21B | 7.93B |
| LongTermDebt | 12.37B | 11.14B | 10.21B | 7.93B |
| CurrentDebtAndCapitalLeaseObligation | 0.00 | 577.00M | 1.44B | 3.19B |
| CurrentDebt | 0.00 | 577.00M | 1.44B | 3.19B |
| OtherCurrentBorrowings | 0.00 | 500.00M | 326.00M | |
| CommercialPaper | 0.00 | 871.00M | 595.00M | 955.00M |
| CurrentNotesPayable | 0.00 | 577.00M | 572.00M | 2.10B |
| PayablesAndAccruedExpenses | 15.99B | 16.10B | 17.16B | 14.80B |
| Payables | 15.99B | 16.10B | 17.16B | 14.80B |
| OtherPayable | 306.00M | 403.00M | 353.00M | 298.00M |
| AccountsPayable | 15.68B | 15.70B | 16.81B | 14.50B |
| TotalAssets | 48.91B | 46.48B | 47.06B | 43.05B |
| InvestmentsAndAdvances | 16.83B | 19.33B | 17.75B | 15.01B |
| LongTermEquityInvestment | 638.00M | 697.00M | 740.00M | 749.00M |
| InvestmentsInOtherVenturesUnderEquityMethod | 638.00M | 697.00M | 740.00M | 749.00M |
| GoodwillAndOtherIntangibleAssets | 10.81B | 11.07B | 11.24B | 10.91B |
| OtherIntangibleAssets | 1.13B | 1.44B | 1.69B | 1.76B |
| Goodwill | 9.69B | 9.63B | 9.55B | 9.14B |
| NetPPE | 2.23B | 2.53B | 3.03B | 3.22B |
| Receivables | 3.27B | 2.70B | 2.04B | 1.67B |
| AccountsReceivable | 3.27B | 2.70B | 2.04B | 1.67B |
| CashCashEquivalentsAndShortTermInvestments | 19.90B | 20.43B | 21.32B | 18.94B |
| OtherShortTermInvestments | 15.70B | 18.21B | 16.63B | 13.88B |
| CashAndCashEquivalents | 4.20B | 2.22B | 4.69B | 5.06B |
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| FreeCashFlow | 375.00M | 2.39B | 2.98B | 3.45B |
| RepurchaseOfCapitalStock | -151.00M | -817.00M | -1.57B | -2.10B |
| RepaymentOfDebt | -1.05B | -2.01B | -2.43B | -3.38B |
| IssuanceOfDebt | 1.48B | 2.28B | 2.91B | 1.98B |
| CapitalExpenditure | -546.00M | -575.00M | -1.00B | -1.14B |
| InterestPaidSupplementalData | 628.00M | 584.00M | 394.00M | 354.00M |
| IncomeTaxPaidSupplementalData | 231.00M | 506.00M | 903.00M | 758.00M |
| EndCashPosition | 4.20B | 2.22B | 4.69B | 5.06B |
| BeginningCashPosition | 2.22B | 4.69B | 5.06B | 3.39B |
| ChangesInCash | 1.98B | -2.47B | -367.00M | 1.67B |
| FinancingCashFlow | -1.22B | -2.49B | -856.00M | -1.91B |
| CashFlowFromContinuingFinancingActivities | -1.22B | -2.49B | -856.00M | -1.91B |
| NetOtherFinancingCharges | -1.28B | -1.93B | 670.00M | 1.97B |
| ProceedsFromStockOptionExercised | 21.00M | |||
| CashDividendsPaid | -430.00M | -431.00M | -431.00M | -392.00M |
| CommonStockDividendPaid | -430.00M | -431.00M | -431.00M | -392.00M |
| NetCommonStockIssuance | -151.00M | -817.00M | -1.57B | -2.10B |
| CommonStockPayments | -151.00M | -817.00M | -1.57B | -2.10B |
| NetIssuancePaymentsOfDebt | 431.00M | 268.00M | 478.00M | -1.39B |
| NetShortTermDebtIssuance | -102.00M | -857.00M | 266.00M | -376.00M |
| ShortTermDebtPayments | -102.00M | -907.00M | -100.00M | -376.00M |
| ShortTermDebtIssuance | 0.00 | 50.00M | 366.00M | 0.00 |
| NetLongTermDebtIssuance | 533.00M | 1.12B | 212.00M | -1.02B |
| LongTermDebtPayments | -948.00M | -1.11B | -2.33B | -3.00B |
| LongTermDebtIssuance | 1.48B | 2.23B | 2.54B | 1.98B |
| InvestingCashFlow | 2.27B | -2.95B | -3.49B | -1.01B |
| CashFlowFromContinuingInvestingActivities | 2.27B | -2.95B | -3.49B | -1.01B |
| NetOtherInvestingChanges | -220.00M | -468.00M | ||
| NetInvestmentPurchaseAndSale | 2.98B | -1.83B | -2.46B | -2.25B |
| SaleOfInvestment | 9.42B | 6.36B | 5.09B | 3.80B |
| PurchaseOfInvestment | -6.44B | -8.19B | -7.55B | -6.05B |
| NetBusinessPurchaseAndSale | 34.00M | -89.00M | -233.00M | 2.36B |
| SaleOfBusiness | 115.00M | 0.00 | 0.00 | 2.70B |
| PurchaseOfBusiness | -81.00M | -89.00M | -233.00M | -337.00M |
| NetPPEPurchaseAndSale | -523.00M | -568.00M | -794.00M | -1.12B |
| SaleOfPPE | 23.00M | 7.00M | 210.00M | 17.00M |
| PurchaseOfPPE | -546.00M | -575.00M | -1.00B | -1.14B |
| OperatingCashFlow | 921.00M | 2.97B | 3.98B | 4.59B |
| CashFlowFromContinuingOperatingActivities | 921.00M | 2.97B | 3.98B | 4.59B |
| ChangeInWorkingCapital | -1.80B | 154.00M | 81.00M | 534.00M |
| ChangeInOtherWorkingCapital | 96.00M | -6.00M | -20.00M | 32.00M |
| ChangeInOtherCurrentLiabilities | 1.32B | -373.00M | 841.00M | 44.00M |
| ChangeInOtherCurrentAssets | -2.17B | 1.00B | -1.32B | -463.00M |
| ChangeInPayablesAndAccruedExpense | -472.00M | 199.00M | 915.00M | 975.00M |
| ChangeInPayable | -472.00M | 199.00M | 915.00M | 975.00M |
| ChangeInAccountPayable | -472.00M | 199.00M | 915.00M | 975.00M |
| ChangeInReceivables | -570.00M | -669.00M | -337.00M | -54.00M |
| OtherNonCashItems | 108.00M | 113.00M | 70.00M | 40.00M |
| StockBasedCompensation | 241.00M | 207.00M | 175.00M | 216.00M |
| AssetImpairmentCharge | 156.00M | 437.00M | 261.00M | 248.00M |
| DeferredTax | 75.00M | -192.00M | -167.00M | -100.00M |
| DeferredIncomeTax | 75.00M | -192.00M | -167.00M | -100.00M |
| DepreciationAndAmortization | 824.00M | 968.00M | 917.00M | 845.00M |
| AmortizationCashFlow | 51.00M | 60.00M | 67.00M | 96.00M |
| AmortizationOfIntangibles | 51.00M | 60.00M | 67.00M | 96.00M |
| Depreciation | 773.00M | 908.00M | 850.00M | 749.00M |
| OperatingGainsLosses | 219.00M | 70.00M | 117.00M | -28.00M |
| EarningsLossesFromEquityInvestments | 102.00M | 94.00M | 63.00M | 4.00M |
| GainLossOnInvestmentSecurities | 50.00M | -24.00M | 54.00M | 205.00M |
| GainLossOnSaleOfBusiness | 67.00M | 0.00 | 0.00 | -237.00M |
| NetIncomeFromContinuingOperations | 1.20B | 1.21B | 2.48B | 2.80B |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for HUM
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|